F. Hoffmann-La Roche Ltd

Phase II neoadjuvant study of GDC-9545+palbociclib (palbo) vs anastrozole (A) plus palbo in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC) (2021) Hurvitz SA, Fasching P, Park YH, Quiroga V, Crnjevic TB, Fresco R, Lopez-Valverde V, et al. Conference contribution A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS (2021) Maccari ME, Fuchs S, Kury P, Andrieux G, Bengsch B, Lorenz MR, Heeg M, et al. Journal article Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study (2021) Hurvitz SA, Park YH, Bardia A, Quiroga V, Lopez-Valverde V, Steinseifer J, Moore HM, et al. Conference contribution Influence of Inter-Annotator Variability on Automatic Mitotic Figure Assessment (2021) Wilm F, Bertram CA, Marzahl C, Bartel A, Donovan TA, Assenmacher CA, Becker K, et al. Conference contribution Dataset on Bi- and Multi-nucleated Tumor Cells in Canine Cutaneous Mast Cell Tumors (2021) Bertram CA, Donovan TA, Tecilla M, Bartenschlager F, Fragoso M, Wilm F, Marzahl C, et al. Conference contribution Obinutuzumab-induced b cell depletion reduces spinal cord pathology in a cd20 double transgenic mouse model of multiple sclerosis (2020) Breakell T, Tacke S, Schropp V, Zetterberg H, Blennow K, Urich E, Kürten S Journal article First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays (2020) Boulo S, Kuhlmann J, Andreasson U, Brix B, Venkataraman I, Herbst V, Rutz S, et al. Journal article KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer (2019) Mamounas EP, Geyer CE, Huang CS, Mano MS, Loibl S, Untch M, Wolmark N, et al. Conference contribution Residual Seal Force Testing: A Suitable Method for Seal Quality Determination of (High Potent) Parenterals (2019) Bücheler J, Luemkemann J, Gieseler H, Mohl S, Streubel A Journal article Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer (2019) Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, et al. Journal article